← Leaderboards
Victoria Parikh
Stanford University
$3,099,082
Attributed
$3,099,082
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $916.8K · FY2016–25$1M$750K$500K$250K$0
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$3,099,082 · 3
By mechanism
R01$2,267,604 · 1
K08$724,970 · 1
F32$106,508 · 1
Top collaborators
No co-investigators on record.
Most similar at Stanford University
Same institution · by research overlap
- Joseph C Wu$80,370,369
- Jesse M Engreitz$13,286,146
- Michael S Kapiloff$15,217,225
- James A Spudich$18,041,927
- Thomas None Quertermous$63,279,401
Others in their field
Top investigators on “Cardiac”
- Judith S Hochman · New York University School Of Medicine$110,228,771
- Anne Christine Gelijns · Icahn School Of Medicine At Mount Sinai$69,868,084
- Rose A Gubitosi-Klug · Case Western Reserve University$61,225,818
- Alfred G Gilman · University Of Texas Sw Med Ctr/Dallas$53,141,827
- Joseph C Wu · Stanford University$53,027,789
- Pamela Susan Douglas · Duke University$51,506,531
Research focus
CardiacTranscriptArrhythmogenic CardiomyopathyTissuesTranscriptome SequencingVariantInduced Pluripotent Stem CellGenesCellsArrhythmiaPathogenicityPhenotypeProtein IsoformsRna SplicingExonsGeneticGenetic TranscriptionHeart FailureCalciumInnovationCardiac MyocytesCardiomyopathiesRegulationPrevent
Grant awards (10)
Pathogenic hotspots illuminate mechanism and therapeutic potential in arrhythmogenic cardiomyopathy$750,316
R01 · FY2025 · HL · contact PI
Pathogenic hotspots illuminate mechanism and therapeutic potential in arrhythmogenic cardiomyopathy$745,470
R01 · FY2024 · HL · contact PI
Pathogenic hotspots illuminate mechanism and therapeutic potential in arrhythmogenic cardiomyopathy$771,818
R01 · FY2023 · HL · contact PI
The Role of RBM20 Sequence and Expression in Dilated Cardiomyopathies$144,994
K08 · FY2023 · HL · contact PI
The Role of RBM20 Sequence and Expression in Dilated Cardiomyopathies$144,994
K08 · FY2022 · HL · contact PI
The Role of RBM20 Sequence and Expression in Dilated Cardiomyopathies$144,994
K08 · FY2021 · HL · contact PI
The Role of RBM20 Sequence and Expression in Dilated Cardiomyopathies$144,994
K08 · FY2020 · HL · contact PI
The Role of RBM20 Sequence and Expression in Dilated Cardiomyopathies$144,994
K08 · FY2019 · HL · contact PI
An Essential Role for miR-29b in the Protective Effect of Apelin in Diabetic Vascular Stiffness$41,731
F32 · FY2018 · HL · contact PI
An Essential Role for miR-29b in the Protective Effect of Apelin in Diabetic Vascular Stiffness$64,777
F32 · FY2016 · HL · contact PI